Sign Up Today and Learn More About Zenas BioPharma Stock
Invest in or calculate the value of your shares in Zenas BioPharma or other pre-IPO companies through EquityZen's platform.
Zenas BioPharma Stock (ZEBO)
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
About Zenas BioPharma Stock
Founded
2020
Headquarters
Waltham, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Zenas BioPharma Press Mentions
Stay in the know about the latest news on Zenas BioPharma
Year in photos: Makers, musicians, faces and places of 2024
bizjournals • Dec 20, 2024
Warm Autoimmune Hemolytic Anemia Landscape to Evolve Rapidly from 2024 to 2034 | DelveInsight
einpresswire • Dec 17, 2024
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga • Dec 16, 2024
Guggenheim Reiterates Buy on Zenas BioPharma
benzinga • Dec 03, 2024
Amid broader uncertainty, biopharma market may have reached 'new norm': PitchBook
fiercebiotech • Nov 20, 2024
Zenas BioPharma Management
Leadership team at Zenas BioPharma
Chief Executive Officer
Hua Mu
Board Member
James Boylan
Join now and verify your accreditation status to gain access to:
- Zenas BioPharma current valuation
- Zenas BioPharma stock price
- Available deals in Zenas BioPharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Zenas BioPharma Stock
How to invest in Zenas BioPharma stock?
Accredited investors can buy pre-IPO stock in companies like Zenas BioPharma through EquityZen funds. These investments are made available by existing Zenas BioPharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Zenas BioPharma stock?
Shareholders can sell their Zenas BioPharma stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
